Firebrick Pharma Ltd获准在印度尼西亚进口和销售Nasodine鼻喷雾剂

美股速递
Mar 27

Firebrick Pharma Ltd已获得批准,允许其在印度尼西亚市场进口并销售其产品Nasodine鼻喷雾剂。这一进展标志着该公司在拓展东南亚市场方面迈出了重要一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10